warden hill chemist limited Company Information
Company Number
03844442
Website
www.alphega-pharmacy.co.ukRegistered Address
lynwood house, 373-375 station road, harrow, middlesex, HA1 2AW
Industry
Dispensing chemist in specialised stores
Telephone
01582576571
Next Accounts Due
October 2025
Group Structure
View All
Shareholders
starcroft investments limited 100%
warden hill chemist limited Estimated Valuation
Pomanda estimates the enterprise value of WARDEN HILL CHEMIST LIMITED at £163.9k based on a Turnover of £567.8k and 0.29x industry multiple (adjusted for size and gross margin).
warden hill chemist limited Estimated Valuation
Pomanda estimates the enterprise value of WARDEN HILL CHEMIST LIMITED at £161.7k based on an EBITDA of £38.1k and a 4.25x industry multiple (adjusted for size and gross margin).
warden hill chemist limited Estimated Valuation
Pomanda estimates the enterprise value of WARDEN HILL CHEMIST LIMITED at £1.7m based on Net Assets of £689.3k and 2.48x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Warden Hill Chemist Limited Overview
Warden Hill Chemist Limited is a live company located in harrow, HA1 2AW with a Companies House number of 03844442. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in September 1999, it's largest shareholder is starcroft investments limited with a 100% stake. Warden Hill Chemist Limited is a mature, small sized company, Pomanda has estimated its turnover at £567.8k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Warden Hill Chemist Limited Health Check
Pomanda's financial health check has awarded Warden Hill Chemist Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
4 Regular
4 Weak
Size
annual sales of £567.8k, make it smaller than the average company (£12.9m)
- Warden Hill Chemist Limited
£12.9m - Industry AVG
Growth
3 year (CAGR) sales growth of -38%, show it is growing at a slower rate (7.6%)
- Warden Hill Chemist Limited
7.6% - Industry AVG
Production
with a gross margin of 30.4%, this company has a comparable cost of product (30.4%)
- Warden Hill Chemist Limited
30.4% - Industry AVG
Profitability
an operating margin of 6.4% make it more profitable than the average company (2.1%)
- Warden Hill Chemist Limited
2.1% - Industry AVG
Employees
with 5 employees, this is below the industry average (80)
5 - Warden Hill Chemist Limited
80 - Industry AVG
Pay Structure
on an average salary of £23k, the company has an equivalent pay structure (£23k)
- Warden Hill Chemist Limited
£23k - Industry AVG
Efficiency
resulting in sales per employee of £113.6k, this is equally as efficient (£132.6k)
- Warden Hill Chemist Limited
£132.6k - Industry AVG
Debtor Days
it gets paid by customers after 44 days, this is later than average (30 days)
- Warden Hill Chemist Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 80 days, this is slower than average (67 days)
- Warden Hill Chemist Limited
67 days - Industry AVG
Stock Days
it holds stock equivalent to 27 days, this is in line with average (30 days)
- Warden Hill Chemist Limited
30 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 228 weeks, this is more cash available to meet short term requirements (16 weeks)
228 weeks - Warden Hill Chemist Limited
16 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 19.4%, this is a lower level of debt than the average (61.7%)
19.4% - Warden Hill Chemist Limited
61.7% - Industry AVG
WARDEN HILL CHEMIST LIMITED financials
Warden Hill Chemist Limited's latest turnover from January 2024 is estimated at £567.8 thousand and the company has net assets of £689.3 thousand. According to their latest financial statements, Warden Hill Chemist Limited has 5 employees and maintains cash reserves of £728 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 5 | 5 | 5 | 5 | 5 | 6 | 8 | 7 | 7 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 6,004 | 8,006 | 8,548 | 10,108 | 13,478 | 17,747 | 23,663 | 880 | 1,173 | 1,563 | 2,084 | 2,778 | 2,264 | 3,019 | 2,393 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 303 | 56,140 | 115,248 | 81,132 | 169,000 |
Total Fixed Assets | 6,004 | 8,006 | 8,548 | 10,108 | 13,478 | 17,747 | 23,663 | 880 | 1,173 | 1,563 | 2,387 | 58,918 | 117,512 | 84,151 | 171,393 |
Stock & work in progress | 30,000 | 30,000 | 29,640 | 0 | 0 | 30,573 | 32,973 | 31,932 | 30,712 | 30,410 | 61,536 | 69,827 | 38,925 | 39,525 | 34,264 |
Trade Debtors | 68,588 | 111,307 | 199,328 | 483,144 | 356,708 | 84,439 | 77,888 | 70,145 | 81,888 | 62,895 | 77,085 | 150,773 | 164,893 | 133,240 | 132,347 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 22,342 | 146,858 | 66,897 | 0 | 0 | 48,628 | 35,901 | 30,945 | 43,996 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 727,962 | 631,450 | 469,517 | 0 | 0 | 151,989 | 94,150 | 97,369 | 105,330 | 149,135 | 166,858 | 68,224 | 12,815 | 250 | 250 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 848,892 | 919,615 | 765,382 | 483,144 | 356,708 | 315,629 | 240,912 | 230,391 | 261,926 | 242,440 | 305,479 | 288,824 | 216,633 | 173,015 | 166,861 |
total assets | 854,896 | 927,621 | 773,930 | 493,252 | 370,186 | 333,376 | 264,575 | 231,271 | 263,099 | 244,003 | 307,866 | 347,742 | 334,145 | 257,166 | 338,254 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 86,739 | 94,142 | 79,438 | 276,321 | 239,673 | 86,061 | 63,755 | 73,591 | 73,749 | 170,319 | 147,155 | 166,286 | 104,421 | 98,377 | 124,009 |
Group/Directors Accounts | 45,260 | 145,260 | 146,259 | 0 | 0 | 143,702 | 130,512 | 75,812 | 118,539 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 33,627 | 51,495 | 90,477 | 0 | 0 | 22,887 | 15,465 | 31,635 | 24,734 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 165,626 | 290,897 | 316,174 | 276,321 | 239,673 | 252,650 | 209,732 | 181,038 | 217,022 | 170,319 | 147,155 | 166,286 | 104,421 | 98,377 | 124,009 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 3,017 | 4,023 | 176 | 234 | 312 | 417 | 556 | 267 | 116 | 197 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 3,017 | 4,023 | 176 | 234 | 312 | 417 | 556 | 267 | 116 | 197 |
total liabilities | 165,626 | 290,897 | 316,174 | 276,321 | 239,673 | 255,667 | 213,755 | 181,214 | 217,256 | 170,631 | 147,572 | 166,842 | 104,688 | 98,493 | 124,206 |
net assets | 689,270 | 636,724 | 457,756 | 216,931 | 130,513 | 77,709 | 50,820 | 50,057 | 45,843 | 73,372 | 160,294 | 180,900 | 229,457 | 158,673 | 214,048 |
total shareholders funds | 689,270 | 636,724 | 457,756 | 216,931 | 130,513 | 77,709 | 50,820 | 50,057 | 45,843 | 73,372 | 160,294 | 180,900 | 229,457 | 158,673 | 214,048 |
Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 2,002 | 2,669 | 5,916 | 7,887 | 293 | 390 | 521 | 694 | 926 | 755 | 1,006 | 798 | |||
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Tax | |||||||||||||||
Stock | 0 | 360 | 29,640 | 0 | -30,573 | -2,400 | 1,041 | 1,220 | 302 | -31,126 | -8,291 | 30,902 | -600 | 5,261 | 34,264 |
Debtors | -167,235 | -8,060 | -216,919 | 126,436 | 223,641 | 19,278 | 12,699 | -24,794 | 62,989 | -14,493 | -129,525 | -73,228 | 65,769 | -86,975 | 301,347 |
Creditors | -7,403 | 14,704 | -196,883 | 36,648 | 153,612 | 22,306 | -9,836 | -158 | -96,570 | 23,164 | -19,131 | 61,865 | 6,044 | -25,632 | 124,009 |
Accruals and Deferred Income | -17,868 | -38,982 | 90,477 | 0 | -22,887 | 7,422 | -16,170 | 6,901 | 24,734 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | -3,017 | -1,006 | 3,847 | -58 | -78 | -105 | -139 | 289 | 151 | -81 | 197 |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -100,000 | -999 | 146,259 | 0 | -143,702 | 13,190 | 54,700 | -42,727 | 118,539 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 96,512 | 161,933 | 469,517 | 0 | -151,989 | 57,839 | -3,219 | -7,961 | -43,805 | -17,723 | 98,634 | 55,409 | 12,565 | 0 | 250 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 96,512 | 161,933 | 469,517 | 0 | -151,989 | 57,839 | -3,219 | -7,961 | -43,805 | -17,723 | 98,634 | 55,409 | 12,565 | 0 | 250 |
warden hill chemist limited Credit Report and Business Information
Warden Hill Chemist Limited Competitor Analysis
Perform a competitor analysis for warden hill chemist limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in HA1 area or any other competitors across 12 key performance metrics.
warden hill chemist limited Ownership
WARDEN HILL CHEMIST LIMITED group structure
Warden Hill Chemist Limited has no subsidiary companies.
Ultimate parent company
1 parent
WARDEN HILL CHEMIST LIMITED
03844442
warden hill chemist limited directors
Warden Hill Chemist Limited currently has 3 directors. The longest serving directors include Mr Nilesh Morjaria (Jan 2005) and Miss Shreena Morjaria (Feb 2022).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Nilesh Morjaria | 64 years | Jan 2005 | - | Director | |
Miss Shreena Morjaria | United Kingdom | 33 years | Feb 2022 | - | Director |
Mrs Sanjita Morjaria | United Kingdom | 63 years | Feb 2022 | - | Director |
P&L
January 2024turnover
567.8k
-23%
operating profit
36.1k
0%
gross margin
30.5%
-5.76%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2024net assets
689.3k
+0.08%
total assets
854.9k
-0.08%
cash
728k
+0.15%
net assets
Total assets minus all liabilities
warden hill chemist limited company details
company number
03844442
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
September 1999
age
25
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
January 2024
previous names
warden hill chemists limited (October 1999)
accountant
-
auditor
-
address
lynwood house, 373-375 station road, harrow, middlesex, HA1 2AW
Bank
-
Legal Advisor
-
warden hill chemist limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to warden hill chemist limited. Currently there are 0 open charges and 1 have been satisfied in the past.
warden hill chemist limited Companies House Filings - See Documents
date | description | view/download |
---|